If you didn't find what you were looking for, try a new search!
This free to member webinar is one recording of the AASM’s Oral Appliance Therapy Series. The entire educational series includes international leaders in the field presenting on all aspects of oral appliance therapy. This particular webinar will describe the patient’s journey with an [...]
Medicare Administrative Contractors (MACs) are denying coverage for oral appliance therapy for the treatment of obstructive sleep apnea (OSA) in cases in which: A patient has been prescribed positive airway pressure (PAP) therapy as the initial treatment for OSA; The PAP rental [...]
A study in the August issue of the Journal of Clinical Sleep Medicine reports that a mandibular advancement device (MAD) can be as successful as continuous positive airway pressure (CPAP) therapy for patients with positional obstructive sleep apnea (OSA).
On Wednesday, Feb. 3, at 5:15 p.m. Eastern Time, the AASM will host a free webinar exploring the recent update to the clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy.
The American Academy of Sleep Medicine (AASM) and the American Academy of Dental Sleep Medicine (AADSM) have published a new clinical practice guideline for oral appliance therapy, which updates the practice parameters that the AASM published in 2006.
In the first official joint guideline from the American Academy of Sleep Medicine (AASM) and American Academy of Dental Sleep Medicine (AADSM), oral appliance therapy is recommended for the treatment of adult patients with obstructive sleep apnea (OSA) who are intolerant of continuous positive airway pressure (CPAP) therapy or prefer alternate therapy.
A study in the September issue of the Journal of Clinical Sleep Medicine involved a one-month crossover trial of both continuous positive airway pressure (CPAP) therapy and oral appliance therapy for obstructive sleep apnea.
American Academy of Sleep Medicine (AASM) President M. Safwan Badr, MD, was recently quoted in a Huffington Post article sharing recommendations on various snoring remedies. While Dr. Badr was happy to contribute, he was disappointed to see that the statements included in the article did not accurately reflect his opinion of or recommendations for oral appliance therapy.
Recently, the four area DME MACs published draft Local Coverage Determinations (LCDs) addressing oral appliance therapy for obstructive sleep apnea. These four policies took effect Jan. 3, 2011.
On Nov. 29, 2023, Vivos Therapeutics announced it received FDA 510(k) clearance for its line of Complete Airway Repositioning and/or Expansion (CARE) oral appliances for the treatment of severe obstructive sleep apnea (OSA). About Vivos CARE oral appliances Vivos’ removable CARE oral appliances represent [...]
On March 21, 2023, Inspire Medical Systems, Inc. announced it received FDA approval to offer Inspire therapy to pediatric patients with Down syndrome. About Inspire therapy Inspire upper airway stimulation is used to treat patients with moderate to severe obstructive sleep apnea (OSA) who [...]
Australian-based Oventus has received clearance from the U.S. Food and Drug Administration for an oral device to treat obstructive sleep apnea, according to a Sept. 2, 2019, company statement. The O2Vent Optima is a customized, 3D-printed, nylon oral device that stabilizes the patient’s upper [...]
The AASM and AADSM are currently inviting public comment on draft guidelines for the treatment of obstructive sleep apnea and snoring with oral appliances. The public comment period is open for 14 days beginning Monday, February 9, 2015 and ending Monday, February 23, 2015. AASM members, AADSM members, nonmember healthcare professionals, patients, insurance and oral appliance companies, advocacy groups, professional medical societies, and other interested members of the public are invited to review the draft guidelines and submit their feedback during this open comment period.
As the number of dentists providing oral appliance therapy has increased in recent years, the American Academy of Sleep Medicine (AASM) and American Academy of Dental Sleep Medicine (AADSM) have received inquiries that seek clarification regarding the scope of practice for physicians and dentists in the diagnosis and treatment of obstructive sleep apnea (OSA).
Three DME carriers have scheduled public meetings to receive and review comments from interested parties regarding recently-released draft local coverage determination (LCD) policies, including "Oral Appliance Therapy for Obstructive Sleep Apnea."
Talking Sleep Season 5 | Episode 19 Medications to Treat Obstructive Sleep Apnea Dr. Sanjay Patel, GUEST We have long known that CPAP therapy isn’t meant for everyone who has obstructive sleep apnea. There are plenty of non-PAP treatment options, including oral appliance [...]
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. State of Sleep Medicine Report for Q3 The quarterly State of Sleep Medicine Report contains news highlights and announcements [...]
Donald Dexter, Jr., DMD, runs a dental sleep medicine practice in Eugene, Oregon. His Native American culture shaped his approach to empathetic, patient-centered care while sparking his creative fire. A passionate supporter of the arts, Dr. Dexter is raising awareness of his heritage with [...]
The following news highlights, many of which have been shared with members through the weekly Insider email, are provided to spark discussion about disruption and future directions in sleep medicine. Large Tech Companies New Google Pixel Watch tracks sleep (Oct. 6) Google recently released [...]
Prosomnus announced Nov. 2, 2022, that it received FDA 510(k) clearance for its ProSomnus EVO [PH] sleep and snore device, a precision oral appliance therapy (OAT) device. About ProSomnus EVO [PH] The ProSomnus EVO [PH] sleep and snore device is intended to reduce nighttime [...]
Jennifer Gibson, AASM Communications Manager Mark Victor, MD, FACC, observed that an increasing number of his cardiology patients also had sleep disorders. As the relationship between obstructive sleep apnea and cardiovascular disease became more evident in the published literature, he recognized that his practice [...]
The State of Sleep Medicine Report is compiled quarterly by the American Academy of Sleep Medicine as a members only resource. The report contains news highlights and announcements to help members identify current trends and innovations in sleep medicine, recognize important developments in health [...]
SLEEP 2022, the 36th annual meeting of the Associated Professional Sleep Societies LLC (APSS), was held on June 4-8, 2022 in Charlotte, North Carolina. Since its inception in 1986, SLEEP has become the premier forum on sleep medicine. Each year, the APSS is proud [...]
The State of Sleep Medicine Report is compiled quarterly by the American Academy of Sleep Medicine as a members only resource. The report contains news highlights and announcements to help members identify current trends and innovations in sleep medicine, recognize important developments in health [...]
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. AASM receives CDC grant for OSA project The CDC has awarded a grant to the AASM for a new, [...]
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Urge Congress to avert Medicare cut! Visit the AASM Action Center to ask your senators and representative to sign [...]
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. From AASM President Dr. Raman Malhotra The voluntary PAP device recall by Philips has been a challenge for our [...]
AASM guidance in response to Philips recall of PAP devices On June 14, 2021, Philips initiated a voluntary recall notification in the U.S. (and an international field safety notice) for specific Philips Respironics models of continuous positive airway pressure (CPAP), bilevel positive airway [...]
Millions of Americans have undiagnosed obstructive sleep apnea, and snoring is one common symptom Nearly 70% of Americans who sleep with a bed partner report that their partner snores while sleeping, according to a 2021 survey* by the American Academy of Sleep Medicine (AASM). [...]
Summary Night Shift Sleep Positioner (by Advanced Brain Monitoring) is an FDA (510 k) cleared device to treat positional sleep apnea. Worn around the neck, it delivers intensifying vibrations until the person moves off of their back. In addition to monitoring position and snoring, [...]
On Feb. 5, 2021, the FDA authorized marketing of a new prescription device, eXciteOSA (formerly Snoozeal), to reduce snoring and mild obstructive sleep apnea. It is the first device used while awake that is intended to improve tongue muscle function, which in time can [...]
The AASM regrets to announce the passing of Rosalind D. Cartwright, PhD, a longtime member and pioneer in the fields of clinical sleep medicine and psychological sleep science. She was born Dec. 30, 1922, and died Jan. 15, 2021, at the age of 98 [...]
